Enwei Pharmaceutical Dividends and Buybacks
Dividend criteria checks 2/6
Enwei Pharmaceutical is a dividend paying company with a current yield of 2.27%.
Key information
2.3%
Dividend yield
1.4%
Buyback Yield
Total Shareholder Yield | 3.7% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.540 |
Payout ratio | 156% |
Recent dividend and buyback updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 301331 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 301331 has only been paying a dividend for 2 years, and since then payments have fallen.
Dividend Yield vs Market
Enwei Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (301331) | 2.3% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (301331) (up to 3 years) | n/a |
Notable Dividend: 301331's dividend (2.27%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 301331's dividend (2.27%) is in the top 25% of dividend payers in the CN market (2.17%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (156.1%), 301331's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 301331 is paying a dividend but the company has no free cash flows.